CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 87 filers reported holding CINCOR PHARMA INC in Q3 2022. The put-call ratio across all filers is 4.10 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $230,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,337,646 | $81,721,000 | 20.22% |
| venBio Partners LLC | 2,145,035 | $40,412,000 | 11.51% |
| Sofinnova Investments, Inc. | 5,573,949 | $105,013,000 | 8.74% |
| Omega Fund Management, LLC | 966,176 | $18,203,000 | 5.81% |
| Sands Capital Ventures, LLC | 950,000 | $17,898,000 | 4.92% |
| GREAT POINT PARTNERS LLC | 669,200 | $12,608,000 | 3.02% |
| BVF INC/IL | 1,644,393 | $30,980,000 | 1.50% |
| Perceptive Advisors | 2,319,117 | $43,692,000 | 1.37% |
| GENERAL ATLANTIC, L.P. | 4,126,470 | $77,743,000 | 1.02% |
| RTW INVESTMENTS, LP | 1,389,705 | $26,182,000 | 0.68% |